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Abstract
Background: Over the last two decades time trends in incidence rates of colorectal cancer,
changes in the proportions of stage at diagnosis and changes in the anatomic sub-site distribution
of colon cancers have been reported in some European countries. In order to determine a strategy
for early detection of colon cancer in the Grand-Duchy of Luxembourg, all consecutive colon
adenocarcinomas diagnosed during the period 1988–1998 at a nation-wide level were reviewed.
Methods: The population-based data of the national Morphologic Tumour Registry report all new
high-grade adenomas (i.e. high-grade intraepithelial adenomatous neoplasias) and all consecutive
new invasive adenocarcinomas of the colon diagnosed in the central department of pathology.
Attention has been focused on variations in incidence, stage, anatomical site distribution and
survival rates. Rectal cancers were excluded.
Results: Over the study period, 254 new colonic high-grade adenomas and 1379 new invasive
adenocarcinomas were found; the crude incidence rates of colon adenocarcinomas grew steadily
by 30%. Comparing the two 5-year periods 1988–1992 and 1994–1998, the crude incidence rates
of high-grade adenomas (stage 0) rose by 190%, that of stage I cases by 14.3%, stage II cases 12.9%
and stage III cases 38.5%, whereas the crude incidence rates of stage IV cases decreased by 11.8%.
The high-grade adenoma/adenocarcinoma ratio increased. The right-sided colonic
adenocarcinomas in elderly patients (>69 years) increased by 76%. The observed survival rates
correlated with tumour stages. The overall observed 5-year survival rate (stage I-IV) was 51 ± 3%
(95% confidence interval).
Conclusion:  The increasing incidence rates of colon adenocarcinomas, the persistence of
advanced tumour stages (stage III), the mortality rates which remain stable, and the changing trends
in the age- and sub-site distribution underline the need for preventive measures at the age of 50 in
asymptomatic patients to reduce mortality from colo(rectal) cancer.
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Background
Since 1994, colorectal adenocarcinoma has been the third
most frequent cancer in the Grand-Duchy of Luxembourg
(Western Europe), preceded by breast and prostatic cancer
[1-3]. In the United States of America (USA), Japan and
France, there have been changes in the site distribution of
large bowel cancers over the last decades [4-9]. Because of
the lack of a systematic, organized screening for colo-rec-
tal cancer in Luxembourg, the data presented here may
help to define new preventive screening approaches, to
increase funding and hasten the introduction of screening
for this tumour. The aim of this study was to investigate
changes in incidence, stage, anatomical site distribution,
and the observed survival rates of colon cancer over two 5-
year periods, 1988–1992 and 1994–1998. Analogous to
the report on rectal cancer published earlier [10], descrip-
tive epidemiological data on colon cancer were collected
to underline the need for the initiation of a nation-wide
strategy for the early detection of colorectal cancer.
Methods
Between January 1st, 1988 and December 31, 1998, all
consecutive new cases of high-grade adenoma and all new
cases of invasive colonic adenocarcinoma (COAC) were
registered by the national Morphologic Tumour Registry
(MTR) in Luxembourg. These cases had been exclusively
diagnosed and "double-read" in the central department of
pathology by nine senior pathologists. Over the decade
the population increased from 374,900 to 429,000, – an
average increase of 1.3% per year. In the elderly age group
>69 years of age, there was a continuous increase by 1.8%
(0.5 – 4.4%) [11]. Patients of all nationalities, race or eth-
nical origin living in Luxembourg were considered. Dis-
ease histology was limited to high-grade adenomas (i.e.
adenomas with severe dysplasia) and invasive adenocarci-
nomas of the colon. Tumours recorded as other carcino-
mas, metastatic or recurrent disease, metachronous
adenomas or invasive adenocarcinomas, malignant carci-
noid and mesenchymal malignant tumours were
excluded from the current review. For patients with syn-
chronous colon neoplasias, only cases with the worst
stage category were taken in account.
Data on patients with high-grade adenomas (i.e. stage 0
patients), who by definition could not have metastases in
regional lymph nodes or distant metastases, were
obtained from 254 biopsy-forceps and polypectomy spec-
imens removed by 26 gastroenterologists and 11 senior-
surgeons. Adenomatous proliferations in marginal zones
of invasive adenocarcinomas and adenomas with severe
dysplasia appearing as recurrent invasive disease within 2
years at the same site were not taken into account.
Data on 1158 surgical resection specimens allowed an
interpretation in relation to the local and regional spread,
the lymph node and the residual tumour status. Hence the
stratification of the invasive colonic adenocarcinomas by
stage (stage I-IV) led to the exclusion of patients with
biopsy diagnosis alone and patients who had only under-
gone polypectomy without segmental resection (i.e. with-
out regional lymphadenectomy). Patients with known
preoperative debulking radiotherapy were not considered.
The surgical resection specimens were analysed with
respect to tumour-stages (stage I to IV), according to the
guidelines of the Union Internationale Contre le Cancer
(UICC) and the American Joint Committee on Cancer
(AJCC) [12-14]. We defined stage I and stage II as early
cancers and stage III and stage IV as advanced colon
cancers.
To evaluate the influence of the number of colonoscopic
procedures on the incidence rates and the stage distribu-
tion of colonic cancers in Luxembourg, the data on colon-
oscopies (1992–1998), gratefully made available by the
National Health Found (NHF), were analysed [15]. The R-
classification according to the TNM-system was per-
formed by conventional methods [16,17]. In our series
the histological examination of the proximal, distal and
lateral (deep) line of resection was mandatory. R0 indi-
cates no residual tumour; R1 corresponds to microscopi-
cally and R2 to macroscopically residual tumour, while Rx
did not allow a statement on residual tumour.
The histopathological diagnoses were made according to
the WHO-classification [18]. On this basis, we defined
'high grade' – adenomas, the equivalent of stage 0 or
former adenocarcinoma in situ, as adenomas of tubular,
villous or tubulo-villous histological type with high-grade
intraepithelial neoplasia (i.e. severe dysplasia). This cate-
gory includes cancer cells confined within the glandular
basement membrane (intraepithelial) or lamina propria
(intramucosal) with no extension through the muscularis
mucosae into the submucosa.
We considered all colon segments as large bowel, with the
exception of the rectum and the recto-sigmoid junction.
Anatomically the rectum was defined as a 16 cm long seg-
ment between the ano-cutaneous line and the sigmoid
colon. Cancers described at the recto-sigmoidal junction
without statement on the centimetres from the anal mar-
gin were considered as rectal adenocarcinomas and were
excluded. Left-sided colon cancers were defined as adeno-
carcinomas of the descending colon and the sigmoid
colon. Right-sided colon cancers included adenocarcino-
mas situated above the splenic flexure (i.e. splenic flexure,
transverse colon, hepatic flexure, ascending colon and
caecum with its prolongation, the appendix vermicularis).
Beside the evaluation of the frequency of invasive COCA
by the 17 'classic' 5-year age categories (0–4 years to 80BMC Cancer 2005, 5:52 http://www.biomedcentral.com/1471-2407/5/52
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years and above) the changes of anatomic sub-site distri-
bution in relation to 3 age groups young (<40 years of
age), middle aged (40–69 years) and elderly (70 years and
above) patients were analyzed. The observed survival rates
of patients with colon cancer were measured from the
time of diagnosis and calculated by the actuarial method
(life-table) with a 95% confidence interval (c.i.). To eval-
uate the observed survival rates in relation to the anatom-
ical extent (stage I-IV) and the surgical resection margins
(R-status), 164 patients with colon adenocarcinoma diag-
nosed only by biopsy-forceps without consecutive surgi-
cal resection data in our files, who were without final stage
and who are part of the 1379 patients with an invasive
COCA, were analysed separately.
The mortality rates of colon cancer were issued from the
anonymous files of the death certificates published by the
National Health Direction (Ministry of Health) [19]. The
age-standardized incidence rates of the colon cancers
diagnosed in the Grand-Duchy of Luxembourg during the
period 1983–1997 were compared with the data of other
geographical European regions with similar population
density and socio-economic characteristics, published by
the WHO in "Cancer in Five Continents, volumes VI, VII,
VIII" [1-3,20-22].
The statistical evaluations include the chi-square test (χ 2)
with a level of significance p < 0.05 and the life-table sur-
vival analysis. The age-standardized incidence rates were
calculated by the direct method, the standard error of the
age-standardized rates by the Poisson approximation
[23].
Results
The histopathological diagnoses of 1379 consecutive
invasive colon adenocarcinomas (COAC) were provided
from 164 samples obtained by biopsy only (11.9%), 57
polypectomy specimens (4.1%) and 1158 surgical resec-
tion specimens (84.0%). The latter allowed a stratification
by stage (UICC/AJCC, 1997) and had reliable follow-up
data. The 1379 invasive adenocarcinomas of the colon
involved 658 males (47.7%) and 721 females (52.3%);
M/F-ratio of 1: 1.1. The mean age was 69.7 years (range:
26–97). During the study period, 254 patients were diag-
nosed with high-grade adenomas. These patients consti-
tute a separate group from the 1379 invasive COAC.
The average, annual, age-specific rates of colon AC in Lux-
embourg over the period 1988–1998 were 31.1 per
100,000 for all ages and both genders, for males 30.3 per
100,000 and for females 31.9 per 100,000 (Figure 1). The
comparison of the crude incidence rates of patients with
colon AC diagnosed in the 5-year periods 1988–1992 and
1994–1998 revealed an increase by 13.5% for both gen-
ders from 28.9 to 32.8, for females by 15.5% from 29.6 to
34.2 and for males by 11.3% from 28.2 to 31.4 per
100,000.
The average, annual, age-standardized incidence rates
(ASR-world population) of colon cancer (period 1988–
1998) were 17.5 per 100,000, for males 20.5 per 100,000
and for females 15.4 per 100,000. Table 1 documents the
world age-standardized incidence rates (ASR/W) of the
invasive COAC in the Luxembourgish population
(females and males) over the period 1983–1997 in com-
parison to other European countries.
The time trend (1988–1998) of the frequency of invasive
COAC showed that the total number of invasive COAC
rose significantly from 109 cases in the year 1988 to 162
cases in 1998 (in females from 61 to 93, in males from 48
to 69). Comparing the two 5-year periods 1988–1992 and
1994–1998, there was a significant increase in the abso-
lute number of all COAC from 557 to 687 cases (p <
0.001). The absolute number of COAC in males increased
significantly from 266 to 323 cases (p < 0.02), and in
females significantly from 291 to 364 cases (p < 0.01).
Figure 2 shows the age-distribution of all patients with
histologically confirmed invasive colonic adenocarci-
noma (n = 1379 cases). Of these patients 1.7% were <40
years of age; 3.8% between 40 and 49 years; 41.0%
between 50 and 69 years; 31.5% between 70 and 79 years
and 22.0% of the patients were 80 years and above.
Concerning the COAC stage distribution, two peculiari-
ties appeared at the extremes of patient age scales. Below
the age of 40, none of the patients (n = 23) had early stage
cancer (i.e. stage I or stage II). On the other hand, out of
the 303 patients aged 80 years and above, most had stage
II (39.0 %) and stage III (38.2 %) disease, whereas stage I
(10.6 %) and stage IV (8.3 %) were much less frequent.
Time trends in relation to the tumour-stages [TNM-Sys-
tem (UICC/AJCC] are represented in Figure 3. During the
two 5-year periods 1988–1992 and 1994–1998, there was
a highly significant increase (p < 0.001) in the crude inci-
dence rates of the stage 0 cases (i.e. high-grade colonic
adenomas) by 190%, an increase in stage I cases by
14.3%, in stage II cases by 12.9%, in stage III cases by
38.5%, and a decrease in stage IV cases by 11.8%.
The relation of the 254 new colonic high-grade adenomas
to the 1379 new invasive adenocarcinomas stratified by
years is shown in Figure 4. The comparison of the average
of crude incidences of the high-grade adenomas to the
invasive adenocarcinomas for the two 5-year periods indi-
cates a highly significant improvement of the ratio by
148% in the second period. There were no significantBMC Cancer 2005, 5:52 http://www.biomedcentral.com/1471-2407/5/52
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changes in the number or crude incidences of colorectal
endoscopies or colonoscopies with biopsy examinations.
The distribution of the 1244 new invasive colon adeno-
carcinomas by anatomical site and two 5-year periods
(1988–1992: n = 557 cases and 1994–1998: n = 687
cases) are given in Figure 5. Twelve cases (1.0%), which
were not otherwise specified, had to be excluded. In rela-
tion to three age groups (< 40 years of age, 40 – 69 years
and >69 years) the anatomical sub-site distribution shows
a shift to right-sided colon adenocarcinomas by 9.2% in
the 40 to 69 years age group (n = 553) and by 76.2% in
the group of patients of >70 years of age (n = 658). The
number of the left-sided colon cancers decreased by
14.5% in the 40–69 years age group and increased by
22.9% in those >70 years. Patients with no precise site and
those of the year 1993 were excluded for statistical (two 5-
year periods) comparison reasons. In Table 2 the anatom-
ical sub-site distribution in relation to the three age
groups and their age-specific rates per 100,000 is
represented.
The overall observed survival rates of the 1379 patients
with an invasive COAC, diagnosed by biopsy or polypec-
tomy or surgical resection specimen were calculated and
stratified by years: 1-year: 72 ± 2% (n = 997/1379); 2-year:
60 ± 3% (833/1379); 3-year: 54 ± 3% (n = 740/1379); 4-
year: 48 ± 3% (n = 662/1379) and 5-year 44 ± 3% (n =
604/1379).
Time trend of the crude incidence rates of the invasive colon adenocarcinomas (n = 1379) by gender; 1988–1998 Figure 1
Time trend of the crude incidence rates of the invasive colon adenocarcinomas (n = 1379) by gender; 1988–1998.
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In Table 3, the observed 5-year survival rates of 931 inva-
sive COAC stratified by stage and operation for cure (R0),
and those of 58 patients with COAC with microscopically
(R1) or macroscopically (R2) residual tumour after surgi-
cal resection are represented. The analysis of the observed
survival rates of the 164 patients with colon AC, diag-
nosed by biopsy-forceps only (i.e. without known final
stage), revealed that 70 patients (42.7%) survived 12
months, whereas 20 (12.2%) died in the first month after
diagnosis, 46 (28.1%) within the next 6 months and 28
(17.1%) in the period from 6 to 12 months. The age-dis-
tribution of these patients showed that 10 (6.1%) patients
were <50 years, 105 (64.0%) were aged between 50 and
79 years and 49 (29.9%) were >80 years of age.
The mortality rates for colon cancer in the Grand-Duchy
of Luxembourg over the last 15 years (1984–1998),
grouped by 5-year periods, did not change significantly
(Table 4) [19]. There was a slight, insignificant (p < 0.05)
decrease in the crude death rates from 26.3 per 100,000 in
the period 1984–1988 to 23.8 per 100,000 in the period
1989–1993 and 23.9 per 100,00 in 1994–1998 [19].
Discussion
In contrast to the USA and Canada, the age-standardized
incidence rates of colon cancer in Luxembourg steadly
increased from 1983–1997 for both genders (Table 1).
Our findings are in concordance with those of many other
European countries, where the increase occurs mainly in
the male population [20-22,24]. Some authors believe
that the decreasing incidence rates in the USA are due to
preventive cancer screening [25]. We found 3.2% cases
with synchronous colon adenocarcinomas, which is com-
parable to the 3.0% and 4.8% of synchronous cancers
identified by authors in other countries [26,27].
The effect of age was examined in relation to the classic
age groups and in relation to three cohorts of patients, (a)
under 40 years of age, (b) between 40 and 69 years, and
(c) 70 years and older. The number of colon cancers
increases around the age of 45 (Figure 2). This is consist-
ent with the findings of Imperiale et al., who found a low
incidence of colon adenomas in the age groups 40 to 49
years [28]. Patients under 40 years of age had a higher
incidence of advanced stage colon cancers. Similar obser-
vations were reported by Mostafa et al. [29].
Considering that high-grade adenomas are obligate pre-
cancerous lesions with a slow progression, that polypec-
tomy can mean prevention of cancer, and that the high-
grade adenoma/invasive adenocarcinoma ratio (Figure 4)
improved in the late 1990's, we observed evidence of ear-
lier diagnoses [30]. We consider the continous registration
of high-grade adenomas and determination of the ade-
noma-adenocarcinoma ratio as a useful additional quality
assurance marker in evaluating clinical and histopatho-
logical diagnostic procedures. To explain the unexpected
increase of precancerous colonic lesions, we analysed our
files in order to identify parameters that might have
changed, such as staff composition or other factors. Over
the period 1992–1995 the number of physicians (n = 38)
practicing endoscopy did not change and the number of
high-grade adenomas (n = 109 cases) removed by each
endoscopist varied between one and six cases. Consider-
Table 1: Colon cancer in the European Community: world age-standardizedincidence rates [ASR(W)*], time trends: 1983–1987; 1988–
1992; 1993–1997.
Males 83–87 88–92 93–97 Females 83–87 88–92 93–97
F/Bas Rhin 27.2 30.2 31.3 ↑ D/Saarland 19.4 20.4 21.5 ↑
D/Saarland 23.7 25.5 27.3 ↑ NL/Maastricht 17.1 17.9 19.4 ↑
I/Parma 23.0 24.4 27.0 ↑ DK/Denmark 19.3 19.9 18.6 ↓
IRL/Southern 21.8 24.2 25.3 ↑ IRL/Southern 19.7 20.3 18.3 ↓
E/Navarra 13.8 19.2 22.1 ↑ I/Parma 16.1 17.8 17.9 ↑
NL/Maastricht 19.7 21.9 22.1 ↑ UK/South Western 15.9 16.2 17.3 ↑
UK/South Western 18.2 19.2 22.1 ↑ F/Bas Rhin 17.4 18.8 16.9 ↓
L/Luxembourg 15.5 20.2 21.9 ↑ L/Luxembourg 11.3 14.9 15.0 ↑
DK/Denmark 20.3 20.6 20.7 ↑ S/Sweden 15.8 15.9 15.0 ↓
CH/St.Gall 16.4 16.5 19.7 ↑ E/Navarra 9.6 13.0 12.4 ↑
S/Sweden 17.5 17.7 17.7 ↔ CH/St.Gall 11.7 12.0 12.1 ↑
SF/Finland 11.9 12.8 14.5 ↑ SF/Finland 10.6 11.6 12.1 ↑
CND/Canada 27.8 26.9 25.9 ↓ CND/Canada 23.6 21.3 20.0 ↓
USA/Seer**, white 31.1 28.1 25.5 ↓ USA/Seer**, white 23.6 20.8 19.4 ↓
* Cancer incidence in five continents. Vol VI; Vol VII; Vol VIII [20, 21, 22]
** SEER: Surveillance, Epidemiology and End Results ProgramBMC Cancer 2005, 5:52 http://www.biomedcentral.com/1471-2407/5/52
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Age-distribution of the invasive colonic adenocarcinomas (n = 1379 cases); 1988–1998 Figure 2
Age-distribution of the invasive colonic adenocarcinomas (n = 1379 cases); 1988–1998.
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Crude incidence rates of the high-grade adenomas (n = 254) and the invasive adenocarcinomas of the colon (n = 1379) strati- fied by stage (TNM/UICC-AJCC, 1997) [14] Figure 3
Crude incidence rates of the high-grade adenomas (n = 254) and the invasive adenocarcinomas of the colon (n = 1379) strati-
fied by stage (TNM/UICC-AJCC, 1997) [14].
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ing that, the number and the crude annual incidence rate
of the colonoscopies did not rise significantly over the
time, that the staff of pathologists remained the same, the
histopathological criteria and coding did not change, and
that a systematic organized screening programme until
the year 2000 was not launched and a spontanous, unor-
ganized screening is not known, we believe that a more
selective indication for colonoscopy examinations may be
one of the causes of this increase. The abrupt change after
1993 in the number of stage 0-cases may be the conse-
quence of the changes in the statute of the National
Health Fund. In 1992 the notions of patients and medical
care providers 'profiling' at the national level were
introduced. At the same time, the media campaign for pre-
ventive medical care strategies against cancer (breast,
malignant melanoma) launched by the governmental
institutions in collaboration with the NHF and the Lux-
embourg Foundation against Cancer may have had a ben-
eficial (secondary) effect. Not only the incidence of stage
0-cases rose, but we found also a positive influence on the
crude incidence rates of stage I and stage II patients
increasing over the two 5-year period (1988–1992) and
(1994–1998) by 14.3 and 12.9% respectively. Unfortu-
nately there has been a highly significant (p < 0.001)
increase in stage III patients by 38.5% too. Colon AC in
young patients (40 years of age or less) seems to be more
aggressive, since those patients were diagnosed exclusively
in stage III and stage IV. Since these patients often present
Crude incidence rates and colonic high-grade adenoma / invasive adenocarcinoma-ratio in comparison to colonoscopies: 1988– 1998; both genders; n = 254*/1379 cases (*diagnoses by biopsy only included) Figure 4
Crude incidence rates and colonic high-grade adenoma / invasive adenocarcinoma-ratio in comparison to colonoscopies: 1988–
1998; both genders; n = 254*/1379 cases (*diagnoses by biopsy only included).
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a positive family history of colorectal cancer, there is an
obvious need for health-care providers to heighten aware-
ness, and to identify high risk persons in this population
group [25,31,32].
In North America, Japan, France and other high-risk areas,
there has been a proximal shift in the sub-site distribution
of colorectal cancer [4,29,32-34]. Similar changes have
occurred in Luxembourg. This proximal shift was found in
both sexes, especially in patients aged 70 and above. In
males the increase was 14.0%, in females 73.6%. Mitry et
al. [33] found that right colon cancer rates had increased
by 21.6% in males and 10.4% in females. This underlines
the need to discuss the opportunity for total colonoscopy
in patients of higher risk or elderly age groups [30].
In our cohort, the overall 5-year survival rates of the
patients with surgery for colon cancer without distinction
of the residual tumour-status were 46 ± 3% (95% c.i.).
Because the data on age-specific risk of death from other
causes than colon cancer during the 1990's are not yet
available, the relative survival rates could not be calcu-
lated. It must be admitted that relative survival rates will
give better data for colon cancer in Luxembourg than indi-
cated by the observed survival rates reported here. The rel-
ative 5-year survival rates reported in the literature vary
between 30.6 and 55.3% [6,35].
Number of invasive colonic adenocarcinomas (n = 1244; cases of the year 1993 excluded) by anatomic site; 1988–1992 and  1994–1998 Figure 5
Number of invasive colonic adenocarcinomas (n = 1244; cases of the year 1993 excluded) by anatomic site; 1988–1992 and 
1994–1998. (N.O.S.* = not otherwise specified)
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Because COAC incidence increases at the age 50 approxi-
mately in our series, because a significant shift to right-
sided colon cancer has been detected in patients of 70
years of age and above and because survival rates would
probably improve if the disease is treated in its early
stages, a strategy to perform twice-lifetime colonoscopy
(at ages 50 and 60 years or at the transition to the pension
age with 65 years) for asymptomatic patients without
family history or other risk factors, as discussed by others,
needs further investigations [4,29,34,36,37]
Conclusion
In contrast to the time trends in the USA and Canada, we
found increasing age-standardized incidence rates in
colonic adenocarcinomas and an increase of the crude
incidence rates especially in stage III patients. Despite the
Table 2: Invasive colon adenocarcinomas (n = 1232*) by anatomic site (left and right colon), by age groups (<40 years; 40–69 years; >69 
years) and age-specific incidence rates; 1988–1992 and 1994–1998.
Age groups Number of incident 
cases (ri)
Person- years of 
obervation (ni)
Age-specific rates per 
100,000 (ri/ni)
p-values **
<40 years
colon right 1988–1992 5 1 072 099 0.5 p = n.s.
colon right 1994–1998 9 1 151 878 0.8
colon left 1988–1992 2 1072 099 0.2 p = n.s.
colon left 1994–1998 5 1151 878 0.4
40–69 years
colon right 1988–1992 130 676 772 19.2 p = n.s.
colon right 1994–1998 142 742 577 19.1
colon left 1988–1992 150 676 772 22.2 p = n.s.
colon left 1994–1998 131 742 577 17.6
>69 years
colon right 1988–1992 122 175 629 69.5 p < 0.001
colon right 1994–1998 215 196 145 109.6
colon left 1988–1992 144 175 629 82.0 p = n.s.
colon left 1994–1998 177 196 145 90.2
* excluded colon cancers N.O.S.(n = 12) and those of 1993 (n = 135)
** level of significance p < 0.05; n.s. = not significant
Table 3: Prognoses of invasive colonic adenocarcinomas resected for cure (R0) or with residual tumour (R1+R2) and stratified by 
stage-TNM/UICC [12, 13, 14, 23].
Stage TNM Observed 5-year survival rates (actuarial method, 
95% confidence interval)
UICC, 5th edition R0 R1+R2 p-values ***
I * T1 N0 M0
T2 N0 M0
71 +/- 8%
(n = 129)
100% **
(n = 1)
<0.5188
II * T3 N0 M0
T4 N0 M0
63 +/- 5%
(n = 388)
45 +/- 30%
(n = 11)
<0.2392
III * anyT N1 M0
anyT N2 M0
38 +/- 5%
(n = 331)
4% **
(n = 25)
<0.0007
IV * anyT anyN M1 17 +/- 8%
(n = 83)
5% **
(n = 21)
<0.1584
I-IV * 51 +/- 3%
(n = 931)
14 +/- 9%
(n = 58)
<0.0001
* only surgical specimens with available survival data
** number of cases too low for calculating the 95% confidence interval
*** level of significance p < 0.05BMC Cancer 2005, 5:52 http://www.biomedcentral.com/1471-2407/5/52
Page 11 of 12
(page number not for citation purposes)
4-fold increase in high-grade adenoma diagnoses (i.e.
stage 0 cases), efforts should be reinforced in preventive
strategies to detect more precancerous lesions and/or early
tumour-stages, to reduce the true incidence of advanced
tumour-stages at diagnosis, and by this the mortality rates.
The findings of this study should provide baseline infor-
mation and scientific evidence for the elaboration and
implementation of cancer preventive and intervention
strategies to those populations at average and high-risk for
colorectal cancers. As long as new diagnostic procedures,
such as stool-based DNA-test for colorectal tumours, are
not yet available for mass-screening purposes, and as long
as the effectiveness of a complete colonoscopy screening
for colorectal cancer in asymptomatic patients beginning
at the age of 50 has not been proven by population-based
controlled trials, the data underline the need of at least a
systematic faecal occult blood test (FOBT) screening for
colorectal cancer beginning at the age of 50 [30,38,39].
Our data support mainly that screening could be consid-
ered in preventing deaths from colo(rectal) cancer. The
findings can be used by the national health care authori-
ties to define a screening strategy and to help in deciding
the target age-groups in Luxembourg.
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